Click any headline to read the full summary on CannaBizGuide.

• Tax & FinanceNational•Apr 8, 2026

  Marijuana Sales Are Rising And Alcohol Is On The Decline As Consumer Preferences Evolve, Government Data In Canada Shows

  A new federal report from the Canadian government showed that cannabis sales are rising while alcohol purchases continue to decline, reflecting shifting consumer preferences across Canada. Licensed Canadian cannabis retailers reported strong growth year-over-year, while alcohol sales fell across beer, wine, and spirits categories in most provinces. Analysts attributed the shift to younger consumer cohorts choosing cannabis over alcohol for reasons including health concerns, lower calorie content, and changing social norms around substance use. The trend mirrors similar patterns emerging in US legal cannabis markets. For cannabis operators, the Canadian data supports the long-term thesis that cannabis is capturing market share from alcohol rather than simply creating new consumption.

• Tax & FinanceNational•Apr 8, 2026

  Federally Funded Study Reveals Marijuana Breathalyzer Breakthrough With 3-D Printed Roadside Tool Able To Detect THC

  Researchers announced a major breakthrough in cannabis breathalyzer technology with a study partly funded by the US Department of Justice, demonstrating a 3-D printed roadside testing device capable of detecting THC in breath samples. Current cannabis roadside testing relies on blood or saliva samples that require laboratory analysis, creating significant challenges for law enforcement and delays in DUI cases. The new breathalyzer approach could enable real-time impairment detection similar to alcohol testing. The technology is still in the research phase with commercial deployment years away. For cannabis operators, workable breathalyzer technology could help address employer concerns about workplace impairment and reduce legal exposure for compliant consumers.

• Tax & FinanceNational•Apr 8, 2026

  Virginia Governor Signs Bills To Automatically Legalize Psilocybin Following Federal Approval Of The Psychedelic

  Virginia Governor Abigail Spanberger signed a pair of bills that will legalize a form of psilocybin under state law contingent on federal FDA approval of the psychedelic compound. The legislation creates an automatic trigger mechanism: Virginia's psilocybin law takes effect immediately once federal regulators approve the substance for medical use. Virginia is believed to be the first US state to tie its psychedelic legalization directly to federal action, bypassing the need for a separate state legislative vote. The approach reflects growing bipartisan interest in psychedelic therapy for PTSD and depression treatment. For the broader cannabis and psychedelics industry, Virginia's trigger mechanism creates a template other states may follow.

• Tax & FinanceNational•Apr 8, 2026

  Texas Hemp Businesses Sue State Officials Over New Rules Banning Products Like Smokable THCA Flower

  A coalition of Texas hemp industry leaders and advocacy organizations filed suit against state officials over recently enacted rules banning smokable THCA flower and other hemp-derived THC products. The plaintiffs argue that Texas regulators exceeded their statutory authority by effectively banning products that comply with the 2018 federal Farm Bill's 0.3 percent delta-9 THC limit. The Texas rules would shut down a significant portion of the state's hemp industry, which has grown to hundreds of millions of dollars in annual sales without the benefit of a legal cannabis market. For cannabis operators watching Texas, the litigation is significant because Texas remains the largest US state without any legal recreational or medical cannabis program.

• Tax & FinanceMaryland•Apr 8, 2026

  Maryland Bill To Extend Psychedelics Task Force Through 2027 Heads To Governor’s Desk

  Maryland lawmakers sent Governor Wes Moore a bill extending the state's psychedelics task force through the end of 2027, charging it with studying regulated therapeutic use of psilocybin and MDMA. The extension continues Maryland's methodical exploration of psychedelic therapy frameworks without committing to commercial legalization. The task force is expected to make recommendations on potential licensing structures, patient eligibility criteria, and regulatory oversight. Maryland joins a growing number of states studying psychedelic therapy in response to emerging clinical evidence for PTSD and treatment-resistant depression. For cannabis operators watching adjacent industries, the psychedelics policy track suggests how future psychedelic commercial markets may develop state-by-state.